Palabras clave
Síndrome respiratorio agudo grave
Niño hospitalizado
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Describir las características clínico-epidemiológicas de niños hospitalizados con COVID-19 y evaluar la correlación entre síntomas y tiempo de internación hospitalaria. Métodos: Estudio transversal que incluyó a 48 pacientes ≤12 años, hospitalizados con COVID-19 entre abril de 2020 y junio de 2021, en un hospital pediátrico en el norte de Brasil. La mayoría fueron niños varones (54,2%), procedentes de Macapá, con una edad media de 24 meses. La duración promedio de la internación fue de 5 días para aquellos con síntomas leves (35,4%) y 10 días para los que presentaron el Síndrome Respiratorio Agudo Grave (SRAG) (64,6%). Resultados: El 22,9% de los pacientes necesitaron oxígeno suplementario, 2 niños (4,2%) fueron ingresados en la UCI, y solo se confirmó un caso de Síndrome Inflamatorio Multisistémico (SIM). El hallazgo radiológico principal fue infiltrado intersticial bilateral. No se registraron muertes durante el estudio. Se observó una asociación entre la presencia de malestar respiratorio y una estadía hospitalaria ≥7 días (p 0,017; coeficiente de Cramer 0,4). Sin embargo, no se encontró asociación entre otros síntomas y la duración de la internación hospitalaria. Conclusión: El estudio señaló una baja tasa de pruebas RT-PCR durante la fase de diseminación del virus.
Referencias
ADIR Y, et al. Asthma and COVID-19: an update. European Respiratory Review, 2021; 30(162): 2101052.
ALKAN G, et al. Evaluation of hematological parameters and inflammatory markers in children with COVID-19. Ir. J. Med. Sci, 2022; 191(4): 1725-1733.
BAQUI P, et al. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob. Health, 2020; 8(8): 1018- 1026.
BELLINI T, et al. Characteristics of COVID‐19 patients up to 6 months of age admitted to a paediatric emergency department. Acta Paediatr, 2022; 11(2): 272-274.
BERNARDINO FBS, et al. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev. Bras. Enferm, 2021; 74(1): 20200624.
BHUIYAN MU, et al. Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis. Vaccine, 2021; 39(4): 667-677.
BRASIL. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Brasília, 2021. Disponível em: https ://covid.saude.gov.br/. Acessado em: 28 mai. 2021.
CARSETTI R, et al. The immune system of children: the key to understanding SARS-CoV-2 susceptibility? The Lancet Child & Adolescent Health, 2020; 4(6): 414-416.
DELAHOY MJ, et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021. MMWR Morb Mortal Wkly Rep, 2021; 70(36): 1255-1260.
DONG Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics, 2020; 145(6): 20200702.
EJAZH, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health, 2020; 13(12): 1833-1839.
GEBHARD C, et al. Impact of sex and gender on COVID-19 outcomes in Europe. Biology of Sex Differences, 2020; 11(1): 29.
GUO CX, et al. Epidemiological and clinical features of pediatric COVID-19. Bmc Medicine, 2020; 18(1): 250.
HUETE-PÉREZ JA, et al. Prevalence and risk factors for SARS-CoV-2 infection in children with and without symptoms seeking care in Managua, Nicaragua: results of a crosssectional survey. BMJ Open, 2021; 11(9): 51836.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Pesquisa Nacional por Amostra de Domicílios Contínua, 2021. Disponível em: https ://sidra.ibge.gov.br/tabela/6403. Acessado em: 04 fev. 2022.
KERMALI M, et al. The role of biomarkers in diagnosis of COVID-19 – A systematic review. Life Sci, 2020; 254: 117788.
KIM L, et al. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1– July 25, 2020. MMWR Morbidity and Mortality Weekly Report, 2020; 69(32): 1081-1088.
MATTHAI, J. et al. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children. Indian Pediatr, 2020; 57(6): 533-535.
MUNRO, A.P.S. et al. Covid-19 in children: current evidence and key questions. Curr. Opin. Infect. Dis, 2020; 33(6): 540-547.
MUSTAFA NM; SELIM LA. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis. J. Clin. Virol, 2020; 128: 104395.
NACHEGAJB, et al. Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries. JAMA pediatrics, 2022; 176(3): 216436.
NINO G, et al. Chest X‐ray lung imaging features in pediatric COVID‐19 and comparison with viral lower respiratory infections in young children. Pediatr. Pulmonol, 2021; 56(12): 3892-3898.
NINO G, et al. Pediatric lung imaging features of COVID-19: A systematic review and metaanalysis. Pediatr. Pulmonol, 2021; 56(1): 252-263.
OLIVEIRA EA, et al. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database. Lancet Child Adolesc. Health, 2021; 5(8): 559-568.
PASCARELLA G, et al. COVID-19 diagnosis and management: a comprehensive review. Journal of Internal Medicine, 2020; 288(2): 192-206.
PRATA-BARBOSA A, et al. Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study. J. Peditr, 2020; 96(5): 582-592.
QI K, et al. Clinical, laboratory, and imaging features of pediatric COVID-19: A systematic review and meta-analysis. Medicine, 2021; 100(15): 25230.
RABHA AC, et al. Manifestações clínicas de crianças e adolescentes com COVID-19: relato dos primeiros 115 casos do Sabará Hospital Infantil. Rev. Paul. Pediatr, 2020; 39: 2020305.
RAZA HA, et al. Sex hormones, autoimmunity and gender disparity in COVID‑19. Rheumatology International, 2021; 41(8): 1375-1386.
SAFADI MAP. The intriguing features of COVID-19 in children and its impact on the pandemic. J. Pediatr, 2020; 96(3): 265-268.
SAMADIZADEH S, et al. COVID-19: Why does disease severity vary among individuals? Respiratory Medicine, 2021; 180: 106356.
SWANN OV, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ, 2020; 370: 3249.
TOSO BR, et al. Caracterização da COVID-19 em crianças hospitalizadas. Rev. Soc. Bras. Enferm. Ped, 2020; 20: 36-48.
WANGJ; YUAN X. Digestive system symptoms and function in children with COVID-19: A meta-analysis. Medicine (Baltimore), 2021; 100(11): 24897.
WATERFIELD T, et al. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study. Arch. Dis. Child, 2021; 106(7): 680-686.
WIERSINGA WJ, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 2020; 324(8): 782-793.
WORLD HEALTH ORGANIZATION (WHO). WHO Coronavirus (COVID-19) Dashboard. Disponível em: https://covid19.who.int/table. Acessado em: 28 mai. 2021.
XIA W, et al. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults. Pediatri. Pulmonol, 2020; 55(5): 1169-1174.
ZHAOY, et al. The inflammatory markers of multisystem inflammatory syndrome in children (MIS‐C) and adolescents associated with COVID‐19: A meta‐analysis. J. Med. Virol, 2021; 93(7): 4358-4369.